HIGHLIGHTS
- who: Targeted Plasmalogen and collaborators from the Pereleman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States, Crescenz VA Medical Center have published the article: Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons, in the Journal: (JOURNAL)
- what: This analysis showed that (LA + AA)-PE was the dominant predictor MDA levels.
- how: The individual participant results are presented in Table 4. ranged from 37 to 84 (average=67).
- future: Investigation is needed to confirm this observation however it is possible that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.